Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435747
Status:
WITHDRAWN
Last Update Posted:
2012-03-14
First Post:
2007-02-13
Brief Title:
Efficacy And Safety Of Parecoxib IVIM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
A Double-Blind Comparative Multicenter Study Of The Efficacy And Safety Of Parecoxib IVIM 40 Mg Vs Placebo On Reducing Opioids Consumption Following Sub Muscular Breast Augmentation Surgery
Status:
WITHDRAWN
Status Verified Date:
2012-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The present study aims to compare the pre-emptive analgesic efficacy of parecoxib 40 mg IVIM versus placebo on reducing postoperative acute pain following submuscular breast augmentation Additionally this study is being conducted to evaluate the safety and tolerability of parecoxib in this kind of procedure
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None